Madrigal Pharmaceuticals, Inc.
MDGL
Revenue
321.08M
▲33.82M▲11.77%
3 Months ChangeAssets
1.26B
▼-102.87M▼-7.55%
3 Months ChangeLiabilities
656.90M
▼-79.83M▼-10.84%
3 Months ChangeFree Cash Flow
-88.89M
▲60.62M▲40.55%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-02-19
Form 8-K
ID: 0001628280-26-009476
2026-01-30
Form 8-K
ID: 0001104659-26-008698
2025-12-11
Form 8-K
ID: 0001628280-25-056533
2025-11-04
Form 10-Q
ID: 0001628280-25-048559
2025-11-04
Form 8-K
ID: 0001628280-25-048525
2025-08-05
Form 10-Q
ID: 0001628280-25-037613
2025-08-05
Form 8-K
ID: 0001628280-25-037596
2025-07-30
Form 8-K
ID: 0001104659-25-071928
2025-07-22
Form 8-K
ID: 0001628280-25-035506
2025-06-20
Form 8-K
ID: 0001628280-25-032358